299 related articles for article (PubMed ID: 25079695)
1. Why regenerative stem cell medicine progresses slower than expected.
Rosemann A
J Cell Biochem; 2014 Dec; 115(12):2073-6. PubMed ID: 25079695
[No Abstract] [Full Text] [Related]
2. The inherent ethical challenge of first-in-human pluripotent stem cell trials.
Habets MG; van Delden JJ; Bredenoord AL
Regen Med; 2014 Jan; 9(1):1-3. PubMed ID: 24350999
[No Abstract] [Full Text] [Related]
3. REGENERATIVE MEDICINE. California stem cell agency plots a race to the clinic.
Servick K
Science; 2016 Jan; 351(6268):15. PubMed ID: 26721984
[No Abstract] [Full Text] [Related]
4. State stem cell agency floats idea of $70 million 'Alpha' clinics.
Dolgin E
Nat Med; 2013 Jul; 19(7):798. PubMed ID: 23836206
[No Abstract] [Full Text] [Related]
5. [Stem cells: scientific progress and commercial tactics].
Nau JY
Rev Med Suisse; 2013 Oct; 9(400):1794-5. PubMed ID: 24187755
[No Abstract] [Full Text] [Related]
6. A new paradigm for funding medical research.
Klein R
Stem Cells; 2012 Mar; 30(3):360-2. PubMed ID: 22334458
[No Abstract] [Full Text] [Related]
7. Stem cells on the ballot.
Goldstein LSB; Klein RN
Science; 2021 Jan; 371(6526):215. PubMed ID: 33446531
[No Abstract] [Full Text] [Related]
8. The NIH and the regenerative medicine field.
Rao M
Regen Med; 2012 Mar; 7(2):129-31. PubMed ID: 22397601
[No Abstract] [Full Text] [Related]
9. Stem cell research: time for a dose of realism.
Brooks M
BMJ; 2017 Jan; 356():j443. PubMed ID: 28143810
[No Abstract] [Full Text] [Related]
10. 2010 World Stem Cell Summit--part 1. October 4-6, 2010, Detroit, MI, USA.
Vertès A
IDrugs; 2010 Dec; 13(12):819-21. PubMed ID: 21154132
[TBL] [Abstract][Full Text] [Related]
11. The international translational regenerative medicine center.
Alexis Mde V; Grinnemo KH; Jove R
Regen Med; 2012 Nov; 7(6 Suppl):74-5. PubMed ID: 23210815
[TBL] [Abstract][Full Text] [Related]
12. Trends in the stem cell and regenerative medicine industry.
Ilic D
Regen Med; 2012 Sep; 7(5):645-8. PubMed ID: 22954435
[TBL] [Abstract][Full Text] [Related]
13. Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions 1-31 March 2017.
Ilic D; Berengueras JM
Regen Med; 2017 Jul; 12(5):479-486. PubMed ID: 28722542
[No Abstract] [Full Text] [Related]
14. California institute for regenerative medicine: accelerating stem cell therapies in California and beyond.
Trounson A
Stem Cells; 2012 Mar; 30(3):357-9. PubMed ID: 22334457
[No Abstract] [Full Text] [Related]
15. Wind-down of stem-cell institute leaves a void.
Loring JF
Nature; 2019 Aug; 572(7768):155. PubMed ID: 31391566
[No Abstract] [Full Text] [Related]
16. Stem cells and the heart: ethics, organization and funding.
Martin JF
Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S136-7. PubMed ID: 16501621
[TBL] [Abstract][Full Text] [Related]
17. Global update: USA.
Matthews KR; Rowland ML
Regen Med; 2012 Nov; 7(6 Suppl):126-9. PubMed ID: 23210825
[TBL] [Abstract][Full Text] [Related]
18. Stem cell research and regenerative medicine at King Abdullah International Medical Research Center.
Abumaree MH; Al Askar AS; Kalionis B; Abomaray FM; Jawdat D; Hajeer AH; Fakhoury H; Al Jumah MA
Stem Cells Dev; 2014 Dec; 23 Suppl 1():12-6. PubMed ID: 25457954
[TBL] [Abstract][Full Text] [Related]
19. Stem cell research and therapies in Argentina: the legal and regulatory approach.
de Arzuaga FC
Stem Cells Dev; 2013 Dec; 22 Suppl 1():40-3. PubMed ID: 24304074
[TBL] [Abstract][Full Text] [Related]
20. Regen Med California Institute for Regenerative Medicine Profile CIRM 2.0.
McCormack K
Regen Med; 2016 Dec; 11(8):759-762. PubMed ID: 27908225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
